Synergism through direct covalent bonding between agents: A strategy for rational design of chemotherapeutic combinations
- 1 January 1990
- journal article
- research article
- Published by Wiley in Peptide Science
- Vol. 29 (1), 247-262
- https://doi.org/10.1002/bip.360290129
Abstract
Self-assembling chemotherapeutic agents are mixtures of relatively nontoxic precursors that can combine chemically under physiological conditions to form products with greater cytotoxic and/or antimicrobial activity than either of the precursors. Combinations that form products more rapidly in or near the target (tumor, pathogen, virally infected cell) than in normal tissues will exhibit target-selective synergism, thus exhibiting an antitarget selectivity that is greater than the selectivities of the product (e.g., a hydrazone) and of either precursor (e.g., a hydrazine derivative or ketone) used singly. This paper describes the target-selective cytotoxic synergism of a cationic aldehyde (A) and a cationic acylhydrazine (B) containing a triarylalkylphophonium moiety against Ehrlich ascites carcinoma cells (ELA) in culture, in addition to reviewing previous work on self-assembling cytotoxins. The synergism between A and B is carcinoma selective when the ELA cells (the target) are compared to CV-1, A, B and the hydrazone C resulting from their reaction are lipophilic delocalized cations that selectively inhibit ELA growth relative to CV-1 growth. The hydrazone C is more growth inhibitory than either A or B for both cell lines. A combination of A with an unreactive analogue of B and a combination of B with an unreactive analogue of A did not synergistically inhibit ELA proliferation. The degree of synergism is greater against the ELA cells than against the CV-1 cells. These data, together with hydrazone formation kinetics, suggest that A and B are both concentrated together selectively inside the ELA due to the transmembrane potentials, reacting inside the ELA cells at a higher velocity than inside the CV-1 cells to form the more growth-inhibitory hydrazone C.Keywords
This publication has 35 references indexed in Scilit:
- Methylglyoxal bis(guanylhydrazone) analogs: multifunctional inhibitors for polyamine enzymesEuropean Journal of Medicinal Chemistry, 1987
- Hydrazine sulfate: A current perspectiveNutrition and Cancer, 1987
- Destruction of Leishmania mexicana amazonensis amastigotes within macrophages by lysosomotropic amino acid esters.The Journal of Experimental Medicine, 1986
- Synthesis of (E)-1-(5-chlorothien-2-yl)-2-(1H-imidazol-1-yl)ethanone 2,6-dichlorophenylhydrazone hydrochloride, a novel, orally active antifungal agentJournal of Medicinal Chemistry, 1983
- High-Performance Liquid Chromatographic Studies of Reaction of Hydralazine with Biogenic Aldehydes and KetonesJournal of Pharmaceutical Sciences, 1979
- The Mechanism of Action of Nitro-heterocyclic Antimicrobial Drugs. Primary Target of 1-Methyl-2-nitro-5-vinylimidazole is DNAJournal of General Microbiology, 1977
- Pyruvamide semicarbazone formation. Kinetics, mechanism, and pertinence to pyruvamide-dependent histidine decarboxylaseJournal of the American Chemical Society, 1975
- Mutant of E. coli containing an Altered DNA-dependent RNA PolymeraseNature, 1968
- Studies on the Mechanism of Oxime and Semicarbazone Formation1Journal of the American Chemical Society, 1959
- A QUANTITATIVE STUDY OF SEMICARBAZONE FORMATIONJournal of the American Chemical Society, 1932